Pharma and Biotech
By Josh White
Date: Friday 12 Apr 2024
(Sharecast News) - Oxford Nanopore took the wraps off a "groundbreaking" study using its technology on Friday, shedding light on the measurement of human telomeres - the protective caps at the ends of chromosomes crucial for genome integrity.
By Josh White
Date: Wednesday 06 Mar 2024
(Sharecast News) - Molecular sensing technology developer Oxford Nanopore Technologies reported a fall in total revenue in its preliminary results for 2023 on Wednesday, despite a surge in life science research tool revenue, as it pushed out its forecast for reaching breakeven.
By Benjamin Chiou
Date: Monday 22 Jan 2024
(Sharecast News) - Oxford Nanopore Technologies has appointed Nick Keher, a finance veteran in the life sciences sector, as its new chief financial officer, the DNA/RNA sequencing tech firm announced on Monday.
Currency | UK Pounds |
Share Price | 93.95p |
Change Today | 0.85p |
% Change | 0.91 % |
52 Week High | 275.00 |
52 Week Low | 92.75 |
Volume | 4,665 |
Shares Issued | 859.96m |
Market Cap | £807.93m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
08:02 | 995 @ 95.48p |
08:01 | 208 @ 95.45p |
08:00 | 5 @ 95.50p |
08:00 | 129 @ 93.95p |
08:00 | 3,328 @ 93.95p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research